<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02550899</url>
  </required_header>
  <id_info>
    <org_study_id>KIDS</org_study_id>
    <nct_id>NCT02550899</nct_id>
  </id_info>
  <brief_title>Polyacrylamide Hydrogel Injection Treatment for Anal Incontinence</brief_title>
  <official_title>Polyacrylamide Hydrogel Injection Treatment for Anal Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized study to evaluate the safety and effects of transanal submucosal polyacrylamide
      hydrogel injection therapy for anal incontinence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective randomized study to assess the use of Bulkamid for anal incontinence using
      three different transanal injection techniques .

      Patients with anal incontinence severity Wexner score &gt;7. Standardised injection treatment at
      baseline. Clinical status and subjective symptom evaluation (Wexner score and FIQL) at
      baseline, 2 months, 6 months and 1 year.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wexner overall score</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>FIQL overall score</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Anal Incontinence</condition>
  <arm_group>
    <arm_group_label>Bulkamid injection treatment group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Injection at four sites circumferentially above the dentate line at 12, 3, 6 and 9 o'clock using 4 ml polyacrylamide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bulkamid injection treatment group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>injection at three sites circumferentially above the dentate line at 12, 4 and 8 o'clock using 4 ml polyacrylamide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bulkamid injection treatment group 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>injection at three sites circumferentially above the dentate line at 12, 4 and 8 o'clock using 6 ml polyacrylamide</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transanal submucosal injection group 1</intervention_name>
    <description>Transanal submucosal injection using an anoscope using four sites circumferentially above the dentate line at 12, 3, 6 and 9 o'clock using 4 ml polyacrylamide</description>
    <arm_group_label>Bulkamid injection treatment group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transanal submucosal injection group 2</intervention_name>
    <description>Transanal submucosal injection using an anoscope using three sites circumferentially above the dentate line at 12, 4 and 8 o'clock using 4 ml polyacrylamide</description>
    <arm_group_label>Bulkamid injection treatment group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transanal submucosal injection group 3</intervention_name>
    <description>Transanal submucosal injection using an anoscope using three sites circumferentially above the dentate line at 12, 4 and 8 o'clock using 6 ml polyacrylamide</description>
    <arm_group_label>Bulkamid injection treatment group 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  informed consent, anal incontinence with Wexner score &gt;10

        Exclusion Criteria:

          -  ino additional pregnancies, schedule for pelvic organ surgery within 1 year of
             treatment, current or previous pelvic organ cancer, insulin treated diabetes,
             inflammatory bowel disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Altman, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Karolinska Institutet Danderyd Hospital</affiliation>
  </overall_official>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2015</study_first_submitted>
  <study_first_submitted_qc>September 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2015</study_first_posted>
  <last_update_submitted>January 9, 2016</last_update_submitted>
  <last_update_submitted_qc>January 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Daniel Altman</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fecal Incontinence</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

